Harshpreet Chandok

545 total citations
16 papers, 386 citations indexed

About

Harshpreet Chandok is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Harshpreet Chandok has authored 16 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Harshpreet Chandok's work include Cancer Genomics and Diagnostics (6 papers), BRCA gene mutations in cancer (2 papers) and Muscle Physiology and Disorders (2 papers). Harshpreet Chandok is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), BRCA gene mutations in cancer (2 papers) and Muscle Physiology and Disorders (2 papers). Harshpreet Chandok collaborates with scholars based in United States, India and Canada. Harshpreet Chandok's co-authors include Alexandra M. Nicaise, Carolyn Paisie, Paul Robson, Stephen J. Crocker, Anna Williams, Laura Wagstaff, Valentina Fossati, Cory M. Willis, Joshy George and Daniel W. Youngstrom and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and Cancer Research.

In The Last Decade

Harshpreet Chandok

15 papers receiving 378 citations

Peers

Countries citing papers authored by Harshpreet Chandok

Since Specialization

Citations

This map shows the geographic impact of Harshpreet Chandok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harshpreet Chandok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harshpreet Chandok more than expected).

Fields of papers citing papers by Harshpreet Chandok

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harshpreet Chandok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harshpreet Chandok. The network helps show where Harshpreet Chandok may publish in the future.

Co-authorship network of co-authors of Harshpreet Chandok

This figure shows the co-authorship network connecting the top 25 collaborators of Harshpreet Chandok. A scholar is included among the top collaborators of Harshpreet Chandok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harshpreet Chandok. Harshpreet Chandok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Genetic and epigenetic screens in primary human T cells link candidate causal autoimmune variants to T cell networks 2025 ·Nature Genetics ·(unknown), (unknown), (unknown), (unknown), Arpit Mishra, Stephan Pribitzer, (unknown), Harshpreet Chandok, Florence M. Chardon, Troy A. McDiarmid, Hannah A. DeBerg, Jane H. Buckner, Jay Shendure, Carl G. de Boer, Michael H. Guo, Ryan Tewhey, John Ray	0
2	Abstract PD5-01: PD5-01 Genomic and epigenomic BRCA alterations predict adaptive resistance and response to platinum-based therapy in triple negative breast cancer and ovarian carcinoma 2023 ·Cancer Research ·Francesca Menghi, Kalyan Banda, Pooja Kumar, Robert F. Straub, Lacey E. Dobrolecki, Isabel Rodríguez, Susan E. Yost, Harshpreet Chandok, Marc R. Radke, George Somlo, Yuan Yuan, Michael T. Lewis, Elizabeth M. Swisher, Edison Liu	1
3	Genomic and epigenomic BRCA alterations predict adaptive resistance and response to platinum-based therapy in patients with triple-negative breast and ovarian carcinomas 2022 ·Science Translational Medicine ·Francesca Menghi, Kalyan Banda, Pooja Kumar, Robert F. Straub, Lacey E. Dobrolecki, (unknown), Susan E. Yost, Harshpreet Chandok, Marc R. Radke, George Somlo, Yuan Yuan, Michael T. Lewis, Elizabeth M. Swisher, Edison T. Liu	33
4	RNA-Seq for the detection of gene fusions in solid tumors: development and validation of the JAX FusionSeq™ 2.0 assay 2022 ·Journal of Molecular Medicine ·(unknown), Harshpreet Chandok, Qian Nie, (unknown), (unknown), Kevin Kelly, Guruprasad Ananda, (unknown), Honey V. Reddi	7
5	3D patient-derived tumor models to recapitulate pediatric brain tumors In Vitro 2022 ·Translational Oncology ·Min D. Tang‐Schomer, Harshpreet Chandok, (unknown), Ching C. Lau, Markus J. Bookland, Joshy George	14
6	Local versus systemic control of bone and skeletal muscle mass by components of the transforming growth factor-β signaling pathway 2021 ·Proceedings of the National Academy of Sciences ·Yewei Liu, (unknown), (unknown), Harshpreet Chandok, Yun‐Sil Lee, Daniel W. Youngstrom, Joshy George, Martin M. Matzuk, Emily L. Germain‐Lee, Se‐Jin Lee	14
7	Targeting myostatin/activin A protects against skeletal muscle and bone loss during spaceflight 2020 ·Proceedings of the National Academy of Sciences ·Se‐Jin Lee, (unknown), Jessica U. Meir, Christina Koch, Andrew Morgan, L. E. Warren, (unknown), Daniel W. Youngstrom, Harshpreet Chandok, Joshy George, Joseph Gogain, Michael Michaud, Thomas A. Stoklasek, Yewei Liu, Emily L. Germain‐Lee	83
8	Molecular profiling of gynecologic cancers for treatment and management of disease – demonstrating clinical significance using the AMP/ASCO/CAP guidelines for interpretation and reporting of somatic variants 2020 ·Cancer Genetics ·Qian Nie, (unknown), Harshpreet Chandok, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Kevin Kelly, (unknown), Jens Rueter, Honey V. Reddi	3
9	Mutation Yield of a Custom 212-Gene Next-Generation Sequencing Panel for Solid Tumors: Clinical Experience of the First 260 Cases Tested Using the JAX ActionSeq™ Assay 2019 ·Molecular Diagnosis & Therapy ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Qian Nie, Guruprasad Ananda, Harshpreet Chandok, Kevin Kelly, (unknown), Honey V. Reddi	1
10	Molecular profiling of CNS tumors for the treatment and management of disease 2019 ·Journal of Clinical Neuroscience ·Qian Nie, (unknown), Harshpreet Chandok, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Kevin Kelly, Jens Rueter, Honey V. Reddi	6
11	Machine Learning in Biology and Medicine 2019 ·Javad Noorbakhsh, Harshpreet Chandok, R. Krishna Murthy Karuturi, Joshy George	13
12	Technical and Regulatory Considerations for Taking Liquid Biopsy to the Clinic: Validation of the JAX PlasmaMonitor^TM Assay 2019 ·Biomarker Insights ·(unknown), (unknown), Kevin Kelly, (unknown), (unknown), Guruprasad Ananda, Harshpreet Chandok, (unknown), (unknown), Honey V. Reddi	19
13	Cellular senescence in progenitor cells contributes to diminished remyelination potential in progressive multiple sclerosis 2019 ·Proceedings of the National Academy of Sciences ·Alexandra M. Nicaise, Laura Wagstaff, Cory M. Willis, Carolyn Paisie, Harshpreet Chandok, Paul Robson, Valentina Fossati, Anna Williams, Stephen J. Crocker	160
14	Screening, Isolation and Identification of Probiotic Producing Lactobacillus acidophilus Strains EMBS081 & EMBS082 by 16S rRNA Gene Sequencing 2015 ·Interdisciplinary Sciences Computational Life Sciences ·Harshpreet Chandok, Pratik Shah, (unknown), (unknown), (unknown), G. Ravi, (unknown), Srinivas Bandaru, (unknown), Anuraj Nayarisseri	17
15	Screening, isolation and identification of Probiotic producing lactobacillus acidophilus strains EMBS081 & EMBS082 by 16S rRNA gene sequencing 2014 ·Interdisciplinary Sciences Computational Life Sciences ·Harshpreet Chandok, Pratik Shah, (unknown), (unknown), (unknown), G. Ravi, (unknown), Srinivas Bandaru, (unknown), Anuraj Nayarisseri	2
16	Pharmacogenomics of drug resistance in Breast Cancer Resistance Protein (BCRP) and its mutated variants 2013 ·Journal of Pharmacy Research ·Sugunakar Vuree, Nageswara Rao Dunna, Imran Ali Khan, Khalid Khalaf Alharbi, S. Vishnupriya, (unknown), Pratik Shah, Harshpreet Chandok, Mukesh Yadav, Anuraj Nayarisseri	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact